Ronald G. Crystal
35Patents
14h-index
46Co-inventors
81Inventor score
Filing activity: Nov 24, 1989 → Jul 13, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6322536A | Minimally invasive gene therapy delivery and method | Human Necessities | 146 | Expired |
| US6508802B1 | Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heart | Human Necessities | 125 | Expired |
| US5837511A | Non-group C adenoviral vectors | Chemistry; Metallurgy | 122 | Expired |
| US5869037A | Adenoviral-mediated gene transfer to adipocytes | Chemistry; Metallurgy | 98 | Expired |
| US5997509A | Minimally invasive gene therapy delivery device and method | Human Necessities | 69 | Expired |
| US6127525A | Chimeric adenoviral coat protein and methods of using same | Chemistry; Metallurgy | 55 | Expired |
| US6013638A | Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung | Chemistry; Metallurgy | 53 | Expired |
| US5618786A | Aerosolization of protein therapeutic agent | Human Necessities | 33 | Expired |
| US5928944A | Method of adenoviral-medicated cell transfection | Chemistry; Metallurgy | 32 | Expired |
| US5238683A | Aerosol preparation of glutathione and a method for augmenting glutathione level in lungs | Human Necessities | 29 | Expired |
| US6153435A | Nucleic acid that encodes a chimeric adenoviral coat protein | Chemistry; Metallurgy | 26 | Expired |
| US9066966B2 | Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia | Chemistry; Metallurgy | 24 | Active |
| US6159950A | Method of modulating hair growth | Human Necessities | 18 | Expired |
| US5989521A | Method for augmenting a decreased level of reduced glutathione in the lung | Human Necessities | 15 | Expired |
| US6329348A | Method of inducing angiogenesis | Human Necessities | 13 | Expired |
| US10337027B2 | Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxia | Chemistry; Metallurgy | 12 | Active |
| US9682133B2 | Disrupted adenovirus-based vaccine against drugs of abuse | Chemistry; Metallurgy | 8 | Active |
| US6165754A | Method of expressing an exogenous nucleic acid | Chemistry; Metallurgy | 5 | Expired |
| US6518255B2 | Multiple site delivery of adenoviral vector directly into muscle for the induction of angiogenesis | Human Necessities | 4 | Expired |
| US6682728B1 | Efficient and selective adenoviral-mediated gene transfer into vascular neointima | Chemistry; Metallurgy | 3 | Expired |
| US12122844B2 | Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies | Chemistry; Metallurgy | 2 | Active |
| US10946094B2 | Adenoassociated viral mediated persistant anti-VEGF therapy for ovarian cancer | Chemistry; Metallurgy | 1 | Active |
| US11821009B2 | Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery | Chemistry; Metallurgy | 1 | Active |
| US6939540B1 | Method of enhancing bone density | Chemistry; Metallurgy | 1 | Expired |
| US12024568B2 | Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.